BIO-key International Finalizes 1-for-10 Reverse Stock Split to Regain Nasdaq Compliance

summarizeSummary

BIO-key International, Inc. has finalized a 1-for-10 reverse stock split, effective April 29, 2026, to regain compliance with Nasdaq's minimum bid price requirement.

check_boxKey Events · Corporate Governance and Compliance · BKYI

• Reverse Stock Split Finalized

  The Board of Directors has set the reverse stock split ratio at 1-for-10, following stockholder approval on April 20, 2026.

• Effective Date and Trading

  The Certificate of Amendment becomes effective at 5:00 p.m. Eastern Time on April 29, 2026. Common Stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market on April 30, 2026.

• Share Reduction

  The total outstanding shares of Common Stock will be reduced from approximately 10,852,118 to approximately 1,085,212 after the split.

• Purpose for Nasdaq Compliance

  The reverse stock split is intended to position the company for minimum bid price compliance with Nasdaq listing requirements.

auto_awesomeAnalysis · BKYI · Technology

This filing confirms the implementation details of the reverse stock split previously approved by stockholders on April 20, 2026. The Board's decision to set the ratio at 1-for-10 is a critical step for BIO-key International to address its non-compliance with Nasdaq's minimum bid price requirement. While necessary for continued listing, reverse splits are generally viewed negatively by the market as they often signal underlying challenges with a company's stock performance, especially when trading near 52-week lows. Investors should monitor the stock's performance post-split and the company's ability to maintain compliance and execute on its growth goals.